Susquehanna International Group’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-80,200
| Closed | -$206K | – | 14181 |
|
|
2022
Q3 | $206K | Buy |
80,200
+68,200
| +568% | +$170K | ﹤0.01% | 10763 |
|
|
2022
Q2 | $23K | Buy |
+12,000
| New | +$26.2K | ﹤0.01% | 12335 |
|
|
2022
Q1 | – | Sell |
-54,400
| Closed | -$244K | – | 14303 |
|
|
2021
Q4 | $244K | Sell |
54,400
-21,600
| -28% | -$102K | ﹤0.01% | 11010 |
|
|
2021
Q3 | $369K | Buy |
+76,000
| New | +$419K | ﹤0.01% | 10111 |
|
|
2021
Q2 | – | Sell |
-11,100
| Closed | -$78K | – | 13479 |
|
|
2021
Q1 | $78K | Sell |
11,100
-156,400
| -93% | -$1.13M | ﹤0.01% | 11940 |
|
|
2020
Q4 | $1.05M | Sell |
167,500
-2,100
| -1% | -$12.4K | ﹤0.01% | 6617 |
|
|
2020
Q3 | $918K | Buy |
169,600
+40,600
| +31% | +$201K | ﹤0.01% | 6317 |
|
|
2020
Q2 | $673K | Buy |
129,000
+89,400
| +226% | +$397K | ﹤0.01% | 6736 |
|
|
2020
Q1 | $125K | Buy |
+39,600
| New | +$146K | ﹤0.01% | 9162 |
|
|
2019
Q4 | – | Sell |
-71,500
| Closed | -$309K | – | 10894 |
|
|
2019
Q3 | $309K | Buy |
+71,500
| New | +$286K | ﹤0.01% | 8244 |
|
|
2019
Q2 | – | Sell |
-38,300
| Closed | -$205K | – | 11013 |
|
|
2019
Q1 | $205K | Sell |
38,300
-22,000
| -36% | -$142K | ﹤0.01% | 7852 |
|
|
2018
Q4 | $309K | Buy |
+60,300
| New | +$458K | ﹤0.01% | 6946 |
|
|
2018
Q3 | – | Sell |
-101,900
| Closed | -$1.04M | – | 10501 |
|
|
2018
Q2 | $1.04M | Buy |
101,900
+70,300
| +222% | +$796K | ﹤0.01% | 5267 |
|
|
2018
Q1 | $411K | Sell |
31,600
-6,500
| -17% | -$96.8K | ﹤0.01% | 7028 |
|
|
2017
Q4 | $682K | Sell |
38,100
-152,800
| -80% | -$3.19M | ﹤0.01% | 6006 |
|
|
2017
Q3 | $4.79M | Sell |
190,900
-44,000
| -19% | -$1.02M | ﹤0.01% | 2546 |
|
|
2017
Q2 | $5.66M | Buy |
234,900
+96,400
| +70% | +$2.13M | ﹤0.01% | 2260 |
|
|
2017
Q1 | $2.67M | Buy |
138,500
+115,700
| +507% | +$1.82M | ﹤0.01% | 3228 |
|
|
2016
Q4 | $351K | Buy |
22,800
+5,700
| +33% | +$74K | ﹤0.01% | 7671 |
|
|
2016
Q3 | $222K | Buy |
+17,100
| New | +$227K | ﹤0.01% | 7419 |
|
|
2013
Q3 | – | Sell |
-1,808
| Closed | -$66K | – | 8872 |
|
|
2013
Q2 | $66K | Buy |
+1,808
| New | +$77.5K | ﹤0.01% | 7909 |
|
Susquehanna International Group's PRTK Position: Q3 2023 in Review
Susquehanna International Group sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q3 2023, closing a stake of 118,025 shares — an estimated $261K sold.
Susquehanna International Group first reported a position in PRTK in Q2 2013 and held it in 32 quarters. The position peaked at $2.24M in Q4 2017. 0 funds tracked by Wall St. Rank hold PRTK as of Q3 2023.
- Susquehanna International Group reported no remaining Paratek Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
- Susquehanna International Group sold 118,025 Paratek Pharmaceuticals, Inc. shares in Q3 2023, an estimated $261K.
- Susquehanna International Group first reported a position in Paratek Pharmaceuticals, Inc. in Q2 2013 and held it in 32 quarters.
- Susquehanna International Group's Paratek Pharmaceuticals, Inc. position peaked at $2.24M in Q4 2017.
- 0 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q3 2023.
Based on Susquehanna International Group's 13F filing for Q3 2023, filed 14 Nov 2023.